483
Finecure Pharmaceuticals LimitedFinecure Pharmaceuticals Limited – FDA 483, Nov 22, 2024
Record Details
An FDA inspection of Finecure Pharmaceuticals Limited in Ahmedabad, India, revealed a significant deficiency in their drug product stability program. The firm was cited for using a non-stability-indicating test method for assay of stability samples, which failed to analyze component degradation or impurities. This issue impacts the reliability of their stability testing, for which they are responsible under a quality agreement with their U.S. distributor.
View Company Profile
ID · 0f3a5060-ad39-49f4-8cab-1901cd453367
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.